NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

PCR及NGS 為基礎的診斷檢驗的全球市場 (2021-2027年):各市場預測 (產品、終端用戶)、產業分析、地區的展望、成長的潛在性、價格趨勢、市場佔有率

PCR & NGS Based Diagnostic Testing Market Size By Product, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

出版商 Global Market Insights Inc. 商品編碼 1007681
出版日期 內容資訊 英文 136 Pages
商品交期: 2-3個工作天內
價格
PCR及NGS 為基礎的診斷檢驗的全球市場 (2021-2027年):各市場預測 (產品、終端用戶)、產業分析、地區的展望、成長的潛在性、價格趨勢、市場佔有率 PCR & NGS Based Diagnostic Testing Market Size By Product, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027
出版日期: 2021年05月21日內容資訊: 英文 136 Pages
簡介

PCR及NGS 為基礎的診斷檢驗的市場,由於感染疾病的發病率增加與其伴隨的診斷化驗的需求高漲,預計2027年顯示大幅度的成長。

由於新型冠狀病毒感染疾病 (COVID-19)的流行,尤其是在感染率高的地區,診斷檢驗的需求前所未有地那樣高漲。

本報告提供全球PCR及NGS 為基礎的診斷檢驗的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,技術藍圖,市場規模的變化、預測,產品、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 調查手法、調查範圍

第2章 摘要整理

第3章 產業分析

  • 產業的分類
  • 產業形勢
  • 對產業的影響要素
    • 成長要素
    • 潛在的風險&課題
  • 成長的潛在性
  • COVID-19:影響分析
  • 波特分析
  • 競爭情形
  • 消費者動態: 設備的購買、租賃
  • 供應鏈分析
  • PESTEL分析
  • 技術藍圖、今後趨勢

第4章 市場分析、預測:各產品

  • 消耗品
  • 設備
  • 實驗室用品

第5章 市場分析、預測:各終端用戶

  • 醫院、診療所
  • 診斷中心
  • 門診中心
  • 其他

第6章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第7章 企業簡介

  • 策略儀表板
  • Agilent Technologies, Inc
  • Bio-Rad Laboratories, Inc
  • Eppendorf AG
  • Fluotics
  • Hamilton Company
  • Illumina, Inc
  • Integra LifeScience Holdings Corporation
  • MGI Tech Co , Ltd
  • Mascon, Inc.
  • Qiagen
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Thomas Scientific (The Carlyle Group)
  • VWR International (Avantor, Inc.)
目錄
Product Code: 5057

The PCR & NGS based diagnostic testing market is estimated to see steady growth by 2027 due to increasing incidences of infectious diseases and the subsequent rise in demand for diagnostic assays.

Due to the COVID-19 outbreak, there was an unprecedented rise in the requirement for diagnostic testing, particularly in regions with high infection rates.

Since the initial phases of the pandemic, Reverse-transcription PCR (RT-PCR) and Metagenomic next-generation sequencing (mNGS) have been commonly used molecular methodologies for COVID-19 diagnosis.

To speed up the diagnostic process, companies have been producing testing kits that can detect the COVID-19 infection rapidly and accurately.

For instance, in May 2021, XPhyto, a next gen bioscience company, introduced one of the fastest RT-PCR test systems for COVID-19.

The company has recently announced that distributor Max Pharma GmbH would commence the sale of its recently-approved 25-minute RT-PCR test system for COVID-19 (Covid-ID Lab) in Germany from 25th May 2021.

The Covid-ID Lab kit has been registered with the European Union as a commercial in-vitro diagnostic (CE-IVD) test. The test system is a rapid RT-PCR test that carries out qualitative detection of SARS-CoV-2 through the RT-PCR method.

The test, which boasts of a 20-minute PCR run time, has been devised to incorporate both the speed of an antigen test and the accuracy of a PCR test to give quick and precise readings.

On the other hand, next generation sequencing (NGS) diagnostic method has increasingly allowed genetic sequencing with an extensive scope of applications in different sectors of medical research.

The major advantage of NGS is that it can screen for and identify viral agents without requiring previous knowledge of the causative agent .

In October 2020, a team of UCLA researchers developed 'SwabSeq' - a high-throughput testing platform for the novel coronavirus - after witnessing the surging burden of testing during the pandemic. The platform utilizes next-generation sequencing (NGS) as a readout.

SwabSeq uses sample-specific molecular barcodes, which allow thousands of samples to be combined and analyzed simultaneously to detect the presence or absence of SARS-CoV-2 in a single run.

Consequently, these recent technological advancements focused on improving efficacy and precision of diagnostic testing systems are projected to drive market growth through the forecast period.

For comprehensive assessment, the PCR & NGS based diagnostic testing market has been bifurcated based on product, end-use, and region.

In terms of product, the market has further been segmented into consumables, equipment, and labware.

The consumables sub-segment is projected to exhibit a CAGR of around -0.7% over the analysis period owing to high consumption of diagnostic consumables during the outbreak of the COVID-19 pandemic.

Based on end-use, the PCR & NGS based diagnostic testing market has been divided into hospitals and clinics, ambulatory settings, diagnostic centers, and others.

The diagnostic centers sub-segment held more than 36% market share in 2020 due to the high volume of diagnostic tests carried out in diagnostic centers.

Based on the regional landscape, the Latin America market is projected to witness a -1.1% CAGR over the forecast period due to the increased sales of diagnostic test kits after the outbreak of the COVID-19 pandemic.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Base estimates & working
  • 1.3 Forecast calculations
  • 1.4 Data validation
  • 1.5 Data Sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid Sources
      • 1.5.1.2 Unpaid Sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 PCR & NGS based Diagnostic testing industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 End-use trends
    • 2.1.4 Regional trends

Chapter 3 PCR & NGS based Diagnostic Testing Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising importance of diagnostic tests in virus detection
      • 3.3.1.2 Growing usage of NGS technology by pharmaceutical and biopharmaceutical companies
      • 3.3.1.3 Increasing research and developmental (R&D) activities in developed economies
      • 3.3.1.4 High risk of infection in geriatric population
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 High cost of diagnostic testing
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By end-use
  • 3.5 COVID-19 impact analysis
    • 3.5.1 Impact of COVID-19 on global PCR & NGS based diagnostic testing market
    • 3.5.2 Impact of COVID-19 on industry value chain
      • 3.5.2.1 Research and development
      • 3.5.2.2 Manufacturing
      • 3.5.2.3 Marketing
      • 3.5.2.4 Supply
    • 3.5.3 Impact of COVID-19 on industry competition
      • 3.5.3.1 Strategy
      • 3.5.3.2 Product portfolio
      • 3.5.3.3 Business growth
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2020
    • 3.7.1 Company matrix analysis, 2020
    • 3.7.2 Manufacturing scenario
      • 3.7.2.1 List of equipment manufacturers in the U.S., Europe, and Asia
      • 3.7.2.2 List of consumable manufacturers in the U.S., Europe, and Asia
  • 3.8 Consumer dynamics: equipment purchase vs leasing
  • 3.9 Supply chain analysis
  • 3.10 PESTEL analysis
  • 3.11 Technology roadmap and future trends

Chapter 4 PCR & NGS based Diagnostic Testing Market, By Product

  • 4.1 Key segment trends
  • 4.2 Consumables
    • 4.2.1 Market size, by region, 2016 - 2027
  • 4.3 Equipment
    • 4.3.1 Market size, by region, 2016 - 2027
  • 4.4 Labware
    • 4.4.1 Market size, by region, 2016 - 2027

Chapter 5 PCR & NGS based Diagnostic Testing Market, By End-use

  • 5.1 Key segment trends
  • 5.2 Hospitals and clinics
    • 5.2.1 Market size, by region, 2016 - 2027
  • 5.3 Diagnostic centers
    • 5.3.1 Market size, by region, 2016 - 2027
  • 5.4 Ambulatory settings
    • 5.4.1 Market size, by region, 2016 - 2027
  • 5.5 Others
    • 5.5.1 Market size, by region, 2016 - 2027

Chapter 6 PCR & NGS based Diagnostic Testing Market, By Region

  • 6.1 Key regional trends
  • 6.2 North America
    • 6.2.1 Market size, by country, 2016 - 2027
    • 6.2.2 Market size, by product, 2016 - 2027
    • 6.2.3 Market size, by end-use, 2016 - 2027
    • 6.2.4 U.S.
      • 6.2.4.1 Market size, by product, 2016 - 2027
      • 6.2.4.2 Market size, by end-use, 2016 - 2027
    • 6.2.5 Canada
      • 6.2.5.1 Market size, by product, 2016 - 2027
      • 6.2.5.2 Market size, by end-use, 2016 - 2027
  • 6.3 Europe
    • 6.3.1 Market size, by country, 2016 - 2027
    • 6.3.2 Market size, by product, 2016 - 2027
    • 6.3.3 Market size, by end-use, 2016 - 2027
    • 6.3.4 UK
      • 6.3.4.1 Market size, by product, 2016 - 2027
      • 6.3.4.2 Market size, by end-use, 2016 - 2027
    • 6.3.5 France
      • 6.3.5.1 Market size, by product, 2016 - 2027
      • 6.3.5.2 Market size, by end-use, 2016 - 2027
    • 6.3.6 Germany
      • 6.3.6.1 Market size, by product, 2016 - 2027
      • 6.3.6.2 Market size, by end-use, 2016 - 2027
    • 6.3.7 Italy
      • 6.3.7.1 Market size, by product, 2016 - 2027
      • 6.3.7.2 Market size, by end-use, 2016 - 2027
    • 6.3.8 Spain
      • 6.3.8.1 Market size, by product, 2016 - 2027
      • 6.3.8.2 Market size, by end-use, 2016 - 2027
  • 6.4 Asia Pacific
    • 6.4.1 Market size, by country, 2016 - 2027
    • 6.4.2 Market size, by product, 2016 - 2027
    • 6.4.3 Market size, by end-use, 2016 - 2027
    • 6.4.4 India
      • 6.4.4.1 Market size, by product, 2016 - 2027
      • 6.4.4.2 Market size, by end-use, 2016 - 2027
    • 6.4.5 China
      • 6.4.5.1 Market size, by product, 2016 - 2027
      • 6.4.5.2 Market size, by end-use, 2016 - 2027
    • 6.4.6 Japan
      • 6.4.6.1 Market size, by product, 2016 - 2027
      • 6.4.6.2 Market size, by end-use, 2016 - 2027
    • 6.4.7 Australia
      • 6.4.7.1 Market size, by product, 2016 - 2027
      • 6.4.7.2 Market size, by end-use, 2016 - 2027
  • 6.5 Latin America
    • 6.5.1 Market size, by country, 2016 - 2027
    • 6.5.2 Market size, by product, 2016 - 2027
    • 6.5.3 Market size, by end-use, 2016 - 2027
    • 6.5.4 Brazil
      • 6.5.4.1 Market size, by product, 2016 - 2027
      • 6.5.4.2 Market size, by end-use, 2016 - 2027
    • 6.5.5 Mexico
      • 6.5.5.1 Market size, by product, 2016 - 2027
      • 6.5.5.2 Market size, by end-use, 2016 - 2027
  • 6.6 MEA
    • 6.6.1 Market size, by country, 2016 - 2027
    • 6.6.2 Market size, by product, 2016 - 2027
    • 6.6.3 Market size, by end-use, 2016 - 2027
    • 6.6.4 Saudi Arabia
      • 6.6.4.1 Market size, by product, 2016 - 2027
      • 6.6.4.2 Market size, by end-use, 2016 - 2027
    • 6.6.5 South Africa
      • 6.6.5.1 Market size, by product, 2016 - 2027
      • 6.6.5.2 Market size, by end-use, 2016 - 2027

Chapter 7 Company Profiles

  • 7.1 Strategy dashboard, 2020
  • 7.2 Agilent Technologies, Inc
    • 7.2.1 Business Overview
    • 7.2.2 Financial data
    • 7.2.3 Product landscape
    • 7.2.4 Strategic outlook
    • 7.2.5 SWOT analysis
  • 7.3 Bio-Rad Laboratories, Inc
    • 7.3.1 Business overview
    • 7.3.2 Financial data
    • 7.3.3 Product landscape
    • 7.3.4 SWOT analysis
  • 7.4 Eppendorf AG
    • 7.4.1 Business Overview
    • 7.4.2 Financial data
    • 7.4.3 Product Landscape
    • 7.4.4 SWOT analysis
  • 7.5 Fluotics
    • 7.5.1 Business overview
    • 7.5.2 Financial data
    • 7.5.3 Product landscape
    • 7.5.4 SWOT analysis
  • 7.6 Hamilton Company
    • 7.6.1 Business overview
    • 7.6.2 Financial data
    • 7.6.3 Product landscape
    • 7.6.4 Strategic outlook
    • 7.6.5 SWOT analysis
  • 7.7 Illumina, Inc
    • 7.7.1 Business Overview
    • 7.7.2 Financial data
    • 7.7.3 Product landscape
    • 7.7.4 SWOT analysis
  • 7.8 Integra LifeScience Holdings Corporation
    • 7.8.1 Business overview
    • 7.8.2 Financial data
    • 7.8.3 Product landscape
    • 7.8.4 Strategic outlook
    • 7.8.5 SWOT analysis
  • 7.9 MGI Tech Co , Ltd
    • 7.9.1 Business overview
    • 7.9.2 Financial data
    • 7.9.3 Product landscape
    • 7.9.4 SWOT analysis
  • 7.10 Mascon, Inc.
    • 7.10.1 Business Overview
    • 7.10.2 Financial data
    • 7.10.3 Product Landscape
    • 7.10.4 SWOT analysis
  • 7.11 Qiagen
    • 7.11.1 Business Overview
    • 7.11.2 Financial data
    • 7.11.3 Product Landscape
    • 7.11.4 Strategy outlook
    • 7.11.5 SWOT analysis
  • 7.12 Roche Diagnostics
    • 7.12.1 Business Overview
    • 7.12.2 Financial data
    • 7.12.3 Product Landscape
    • 7.12.4 Strategy outlook
    • 7.12.5 SWOT analysis
  • 7.13 Thermo Fisher Scientific
    • 7.13.1 Business Overview
    • 7.13.2 Financial data
    • 7.13.3 Product Landscape
    • 7.13.4 Strategy outlook
    • 7.13.5 SWOT analysis
  • 7.14 Thomas Scientific (The Carlyle Group)
    • 7.14.1 Business Overview
    • 7.14.2 Financial data
    • 7.14.3 Product Landscape
    • 7.14.4 Strategy outlook
    • 7.14.5 SWOT analysis
  • 7.15 VWR International (Avantor, Inc.)
    • 7.15.1 Business Overview
    • 7.15.2 Financial data
    • 7.15.3 Product Landscape
    • 7.15.4 Strategy outlook
    • 7.15.5 SWOT analysis

Data Tables

  • TABLE 1 Diagnostic testing market, 2016 - 2020, (USD Million)
  • TABLE 2 Diagnostic testing market, 2021 - 2027, (USD Million)
  • TABLE 3 Global PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 4 Global PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 5 Global PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 6 Global PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 7 Global PCR & NGS based diagnostic testing market by region, 2016 - 2020 (USD Million)
  • TABLE 8 Global PCR & NGS based diagnostic testing market by region, 2021 - 2027 (USD Million)
  • TABLE 9 Industry impact forces
  • TABLE 10 List of equipment manufacturers in US, Europe, and Asia
  • TABLE 11 List of consumable manufacturers in US, Europe, and Asia
  • TABLE 12 Consumables market by region, 2016 - 2020 (USD Million)
  • TABLE 13 Consumables market by region, 2021 - 2027 (USD Million)
  • TABLE 14 Equipment market by region, 2016 - 2020 (USD Million)
  • TABLE 15 Equipment market by region, 2021 - 2027 (USD Million)
  • TABLE 16 labware market by region, 2016 - 2020 (USD Million)
  • TABLE 17 Labware market by region, 2021 - 2027 (USD Million)
  • TABLE 18 Hospitals and clinics market by region, 2016 - 2020 (USD Million)
  • TABLE 19 Hospitals and clinics market by region, 2021 - 2027 (USD Million)
  • TABLE 20 Diagnostic centers market by region, 2016 - 2020 (USD Million)
  • TABLE 21 Diagnostic centers market by region, 2021 - 2027 (USD Million)
  • TABLE 22 Ambulatory settings market by region, 2016 - 2020 (USD Million)
  • TABLE 23 Ambulatory settings market by region, 2021 - 2027 (USD Million)
  • TABLE 24 Others market by region, 2016 - 2020 (USD Million)
  • TABLE 25 Others market by region, 2021 - 2027 (USD Million)
  • TABLE 26 North America PCR & NGS based diagnostic testing market, by country, 2016 - 2020, (USD Million)
  • TABLE 27 North America PCR & NGS based diagnostic testing market, by country, 2021 - 2027 (USD Million)
  • TABLE 28 North America PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 29 North America PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 30 North America PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 31 North America PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 32 U.S. PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 33 U.S. PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 34 U.S. PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 35 U.S. PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 36 Canada PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 37 Canada PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 38 Canada PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 39 Canada PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 40 Europe PCR & NGS based diagnostic testing market, by country, 2016 - 2020, (USD Million)
  • TABLE 41 Europe PCR & NGS based diagnostic testing market, by country, 2021 - 2027 (USD Million)
  • TABLE 42 Europe PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 43 Europe PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 44 Europe PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 45 Europe PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 46 UK PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 47 UK PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 48 UK PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 49 UK PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 50 France PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 51 France PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 52 France PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 53 France PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 54 Germany PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 55 Germany PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 56 Germany PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 57 Germany PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 58 Italy PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 59 Italy PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 60 Italy PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 61 Italy PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 62 Spain PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 63 Spain PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 64 Spain PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 65 Spain PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 66 Asia Pacific PCR & NGS based diagnostic testing market, by country, 2016 - 2020, (USD Million)
  • TABLE 67 Asia Pacific PCR & NGS based diagnostic testing market, by country, 2021 - 2027 (USD Million)
  • TABLE 68 Asia Pacific PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 69 Asia Pacific PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 70 Asia Pacific PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 71 Asia Pacific PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 72 India PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 73 India PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 74 India PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 75 India PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 76 China PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 77 China PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 78 China PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 79 China PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 80 Japan PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 81 Japan PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 82 Japan PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 83 Japan PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 84 Australia PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 85 Australia PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 86 Australia PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 87 Australia PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 88 Latin America PCR & NGS based diagnostic testing market, by country, 2016 - 2020, (USD Million)
  • TABLE 89 Latin America PCR & NGS based diagnostic testing market, by country, 2021 - 2027 USD Million)
  • TABLE 90 Latin America PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 91 Latin America PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 92 Latin America PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 93 Latin America PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 94 Brazil PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 95 Brazil PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 96 Brazil PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 97 Brazil PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 98 Mexico PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 99 Mexico PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 100 Mexico PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 101 Mexico PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 102 MEA PCR & NGS based diagnostic testing market, by country, 2016 - 2020, (USD Million)
  • TABLE 103 MEA PCR & NGS based diagnostic testing market, by country, 2021 - 2027 (USD Million)
  • TABLE 104 MEA PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 105 MEA PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 106 MEA PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 107 MEA PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 108 Saudi Arabia PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 109 Saudi Arabia PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 110 Saudi Arabia PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 111 Saudi Arabia PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 112 South Africa PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)
  • TABLE 113 South Africa PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)
  • TABLE 114 South Africa PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)
  • TABLE 115 South Africa PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 COVID-19 detection kits data analysis approach
  • FIG. 3 Data validation
  • FIG. 4 PCR & NGS based Diagnostic testing industry 360 degree synopsis, 2016 - 2027
  • FIG. 5 Industry segmentation
  • FIG. 6 Global PCR & NGS based diagnostic testing market, 2016 - 2027 (USD million)
  • FIG. 7 Growth potential analysis, by product
  • FIG. 8 Growth potential analysis, by end-use
  • FIG. 9 Impact of COVID-19 on PCR & NGS based diagnostic testing market, 2020-2022
  • FIG. 10 Impact of COVID-19 on industry value chain
  • FIG. 11 Impact of COVID-19 on industry competition
  • FIG. 12 Porter's analysis
  • FIG. 13 Company matrix analysis, 2020
  • FIG. 14 Supply chain analysis
  • FIG. 15 PESTLE analysis
  • FIG. 16 Key segment trends, by product
  • FIG. 17 Key segment trends, by end-use
  • FIG. 18 Key regional trends
  • FIG. 19 Strategy dashboard, 2020